HomeOwner SearchCategory Search
Visit USCOPharmaceutical Chemistry Journal [Published: 2013-11-21. Issue: vol. 47, no. 7, October 2013]
Serial Registration
Copyright Title
Pharmaceutical Chemistry Journal [Published: 2013-11-21. Issue: vol. 47, no. 7, October 2013]
Status
Published
on 2 Jan 2014
Year of Creation
2013
Copyright Claimant
Springer Science+Business Media LLC
Registration Number
TX0007796513
on 2 Jan 2014Copyright Summary
The U.S. Copyright record (Registration Number: TX0007796513) dated 2 Jan 2014, pertains to an electronic file (eService) titled "Pharmaceutical Chemistry Journal [Published: 2013-11-21. Issue: vol. 47, no. 7, October 2013]" created in 2013. The copyright holder is Springer Science+Business Media LLC, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Springer Science+Business Media LLC.
Application Details
Registration Number
TX0007796513
Registration Date
1/2/2014
Year of Creation
2013
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Springer Science+Business Media LLC
First Publication Nation
United States
ISSN
0091-150X
Preexisting Material
text, Russian Journal previously published
Notes
Copyright Local Holdings: vol. 47, no. 7, October 2013 Created 2013 Pub. 2013-11-21 Reg. 2014-01-20 TX0007796513 PSTAN
Material Matter Claimed Note: translation
Statements
Application Title Statement: Pharmaceutical Chemistry Journal
Author Statement: Springer Science+Business Media LLC employer for hire Domicile: United States Citizenship: United States Authorship: contribution(s) to a collective work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.